---
title: "BioPharma AI Weekly - Issue #15 (2025.04.11)"
date: 2025-04-11
categories: [Weekly News]
published: false
---

# AI Technology Updates

## Anthropic - Model Context Protocol (MCP)
- [Anthropic News](https://www.anthropic.com/news/model-context-protocol)
- Open protocol for LLMs to safely interact with external data/tools; already integrated in Claude Desktop and OpenAI Agents SDK.

## Recursion x Enamine - AI-Enabled Targeted Compound Libraries
- [Recursion-Enamine News](https://ir.recursion.com/news-releases/news-release-details/recursion-and-enamine-release-new-ai-enabled-targeted-compound)
- New screening libraries combining Recursion's AI with Enamine's chemistry, targeting hard-to-drug proteins.

## HITS - Hyper Lab v2.0, New Features
- [Hyper Lab Update](https://medium.com/@gyubkim/2025%EB%85%84-1%EB%B6%84%EA%B8%B0-%ED%9A%8C%EA%B3%A0-%EB%8C%80%EA%B7%9C%EB%AA%A8-%EC%97%85%EB%8D%B0%EC%9D%B4%ED%8A%B8-%EC%99%84%EB%A3%8C-%EC%9C%84%ED%83%9C%EB%A1%9C%EC%9A%B4-%EC%99%B8%EC%A4%84%ED%83%80%EA%B8%B0-%EC%9A%B0%EC%83%81%ED%96%A5-%EB%AA%A9%ED%91%9C-%EB%8B%AC%EC%84%B1%ED%95%98%EA%B8%B0-bbbbcdce53c9)
- Major updates: AI Assistant, Hyper Co-folding (AlphaFold3-based), Hyper Screening X for virtual compound libraries.

## Iktos - Makya 2.0 Preview
- [Iktos Makya 2.0](https://www.linkedin.com/posts/iktos_makya-generativeai-drugdiscovery-activity-7313513480483987456-xCvh?utm_source=share&utm_medium=member_desktop&rcm=ACoAABB8QFcBgDpG12OhReVCfNUvTPyaeekY_sI)
- Next-gen generative AI platform for drug design launching late 2025; new clustering, filtering, analysis, and alignment features.

## Meta - Llama 4 Multimodal LLM Release
- [Meta Blog](https://ai.meta.com/blog/llama-4-multimodal-intelligence/)
- Latest Llama 4 models support text/image multimodality and efficient "mixture of experts" architecture; strong coding and reasoning benchmarks.

# AI in BioPharma

## Syntekabio x Pragma Biosciences - $3.1M Deal for Microbiome Drug Discovery
- [Pharmnews](https://www.pharmnews.com/news/articleView.html?idxno=258720)
- Partnership for AI-optimized oral drug development targeting immune diseases using DeepMatcher platform.

## Isomorphic Labs - $600M Investment for AI Drug Design Platform
- [Isomorphic Labs News](https://www.isomorphiclabs.com/articles/isomorphic-labs-announces-600m-external-investment-round)
- Funds to advance AI-driven drug pipeline and expand pharma partnerships.

# Conferences & Events

## IBM AI Ethics Board - AI Agents: Risks & Mitigations
- [IBM LinkedIn Post](https://www.linkedin.com/posts/andreashorn1_ai-agents-opportunities-risks-and-mitigations-activity-7312898676895440896-D4GX?utm_source=share&utm_medium=member_desktop&rcm=ACoAABB8QFcBgDpG12OhReVCfNUvTPyaeekY_sI)
- Report on emerging risks as AI agents become more autonomous and recommendations for industry governance.

## Pharma Patent Cliff Analysis (BioSpace)
- [BioSpace Article](https://www.biospace.com/business/5-pharma-powerhouses-facing-massive-patent-cliffs-and-what-theyre-doing-about-it)
- Impact and strategies around 2023â€“2025 pharma patent expirations.
